RT Journal Article
SR Electronic
T1 Bringing Critical Race Praxis into the Study of Electrophysiological Substrate of Sudden Cardiac Death: The Atherosclerosis Risk in Communities (ARIC) Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19009167
DO 10.1101/19009167
A1 Jensen, Kelly
A1 Howell, Stacey J.
A1 Phan, Francis
A1 Khayyat-Kholghi, Maedeh
A1 Wang, Linda
A1 Haq, Kazi T.
A1 Johnson, John
A1 Tereshchenko, Larisa G.
YR 2019
UL http://medrxiv.org/content/early/2019/10/22/19009167.abstract
AB Race is an established risk factor for sudden cardiac death (SCD). We sought to determine whether the association of electrophysiological (EP) substrate with SCD varies between black and white individuals. Participants from the Atherosclerosis Risk in Communities study with analyzable ECGs (n=14,408; age 54±6 y; 74% white) were included. EP substrate was characterized by traditional 12-lead ECG and vectorcardiographic metrics. Two competing outcomes were adjudicated SCD and non-sudden cardiac death (nonSCD). Interaction of ECG metrics with race was studied in Cox proportional hazards and Fine-Gray competing risk models, adjusted for prevalent cardiovascular disease (CVD), risk factors, and incident non-fatal CVD. At the baseline visit linear regression analysis, adjusted for age, sex, and study center, showed black individuals had larger Spatial Ventricular Gradient magnitude by 0.30 (95%CI 0.25-0.34) mV, SAI QRST by 18.4 (13.7-23.0) mV*ms, Cornell voltage by 0.30 (95%CI 0.25-0.35) mV than white individuals. Over a median follow-up of 24.4 years, SCD incidence was higher in black (2.86; 95%CI 2.50-3.28 per 1000 person-years) than white individuals (1.37; 95%CI 1.22-1.53 per 1000 person-years). Black individuals with hypertension had the highest rate of SCD: 4.26; 95%CI 3.66-4.96 per 1000 person-years. Race did not modify associations of EP substrate with SCD and nonSCD. EP substrate does not explain racial disparities in SCD rate.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialnot a clinical trialFunding StatementThe Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I). This work was supported by HL118277 (LGT), and OHSU President Bridge funding (LGT).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableThe ARIC Study data are available through the National Heart, Lung, and Blood Institute’s Biological Specimen and Data Repository Information Coordinating Center (BioLINCC) and the National Center of Biotechnology Information’s database of Genotypes and Phenotypes (dbGaP). The MATLAB (MathWorks, Natick, MA, USA) open-source software code for GEH measurement and the heart vector origin definition is provided at https://physionet.org/physiotools/geh and https://github.com/Tereshchenkolab/Origin. https://physionet.org/physiotools/geh https://github.com/Tereshchenkolab/Origin